Reston Breast Program Receives National Accreditation
Recognized by NAPBC for Comprehensive Breast Cancer Care
Reston, Virginia, July 19, 2010 - The Breast Network of Reston Hospital Center's Ann B. Rodriguez Cancer Center has been granted a three-year/Full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons. Accreditation by the NAPBC is only given to those centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance.
During the survey process the NAPBC surveyor, Lauri Wilson, MD, remarked, "The program is a true gem. The experienced staff, breast navigation team, Women's Imaging Center and interdisciplinary care truly impressed me."
"Although the NAPBC designation is fairly new, we have been working on a comprehensive breast cancer treatment program for years," said Jane Raymond, COO of Reston Hospital Center. She continued, "It's a thrill to see it all come to fruition with this recognition."
During the survey process, the breast program demonstrated compliance with standards established by the NAPBC for treating women who are diagnosed with the full spectrum of breast disease. The standards include proficiency in the areas of: center leadership, clinical management, research, community outreach, professional education, and quality improvement. A breast center that achieves NAPBC accreditation has demonstrated a firm commitment to offer its patients every significant advantage in their battle against breast disease.
Receiving care at a NAPBC-accredited center ensures that a patient will have access to:
- Comprehensive care, including a full range of state-of-the-art services
- A multidisciplinary team approach to coordinate the best treatment options
- Information about ongoing clinical trials and new treatment options
And, most importantly,
- Quality breast care close to home.
The American Cancer Society (ACS) estimated that there would be 192,370 patients diagnosed with invasive breast cancer in the United States in 20091. In addition, hundreds of thousands of women who will deal with benign breast disease this year will require medical evaluation for treatment options.